FDA Inspection 1187493 — Bradley S. Taylor, M.D.
The FDA completed an inspection of Bradley S. Taylor, M.D. on Oct 27, 2022 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
Clinical Investigator (CI)